gadoxetic-acid-disodium and Gaucher-Disease

gadoxetic-acid-disodium has been researched along with Gaucher-Disease* in 1 studies

Other Studies

1 other study(ies) available for gadoxetic-acid-disodium and Gaucher-Disease

ArticleYear
Gaucher disease in the liver on hepatocyte specific contrast agent enhanced MR imaging.
    Pediatric radiology, 2017, Volume: 47, Issue:4

    Gaucher disease is a hereditary lipid storage disorder that affects the enzyme beta glucocerebrosidase, causing accumulation of glucocerebroside in macrophages of the reticuloendothelial system. Accumulation can occur in the liver and spleen, manifesting as hepatosplenomegaly, as well as within the bone marrow. Hepatic involvement is usually diffuse but can occasionally manifest as focal liver lesions. We present a case of a 2-year-old boy with Gaucher disease and an infiltrating liver lesion detected on imaging, which was pathologically shown to be focal changes related to the disease. Imaging characteristics of this lesion using hepatocyte specific contrast agent enhanced MRI, which have not been previously discussed in the literature, are described.

    Topics: Child, Preschool; Contrast Media; Gadolinium DTPA; Gaucher Disease; Hepatocytes; Humans; Image Enhancement; Liver; Magnetic Resonance Imaging; Male

2017